TCT-5 Timing for transcatheter closure of ventricular septal rupture after acute myocardial infarction  by Qian, Geng
B2 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5CONCLUSIONS In this population of high risk NSTE-ACS patients,
transient ST elevation was present in 24% of patients. Clinical
outcome at long term follow-up was better as compared to patients
without T-STE. An early invasive strategy in patients with T-STE ACS
was feasible but not superior to a late invasive strategy in terms of the
combined primary endpoint of death, reinfarction and/or recurrent
ischemia. Infarct size was comparable. Postponement of intervention
for prolonged pharmacological pretreatment did not result in
improved outcome. Prospective, randomized trials are necessary for
more evidence in the optimal treatment of these patients. ISRCTN
register 39230163
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BACKGROUND The Thrombus Aspiration in ST-Elevation myocardial
infarction in Scandinavia (TASTE) trial did not demonstrate clinical
beneﬁt of thrombus aspiration (TA). High risk patients might beneﬁt
from TA.
METHODS The TASTE trial was a multicenter, randomized,
controlled, open-label trial obtaining endpoints from national regis-
tries. Patients (n¼7244) with ST segment elevation myocardial
infarction (STEMI) undergoing percutaneous coronary intervention
(PCI) were randomly assigned 1:1 to TA and PCI or to PCI alone. We
assessed the one-year clinical effect of TA in a sub-group with
potentially large anterior STEMI: mid or proximal left anterior
descending coronary artery infarct lesion, TIMI 0-2 ﬂow, and symp-
tom-onset-to-PCI time 5 h. In this sub-study, patient eligibility
criteria corresponded to that of the Intracoronary Abciximab and
Aspiration Thrombectomy in Patients with Large Anterior Myocardial
Infarction (INFUSE-AMI) study.
RESULTS In total, 1826 patients fulﬁlled inclusion criteria. All-cause
mortality at one year of patients randomized to TA did not differ from
those randomized to PCI only [hazard ratio (HR) 1.05, 95% conﬁdence
interval (CI) 0.74-1.49, P¼0.77]. Rates of rehospitalization for
myocardial infarction (MI), heart failure (HF), and stent thrombosis
(ST) did not differ between groups (HR 0.87, 95% CI 0.51-1.46, P¼0.59;
HR 1.10 95% CI 0.77-1.58, P¼0.58; and HR 0.75, 95% CI 0.30-1.86,
P¼0.53; respectively). This was also the case for the combined
endpoint of all-cause mortality, and rehospitalization for MI, HF, or ST
(HR 1.00, 95% CI 0.79-1.26, P¼0.99).CONCLUSIONS In patients with STEMI and large area of myocardium
at risk, TA did not affect outcome within one year.
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BACKGROUND Spontaneous coronary artery dissection (SCAD) is an
infrequent but important cause of myocardial infarction (MI) in
women. Chronic exposure to hormonal therapy, ﬂuctuation in hor-
monal levels, and a history of multiple pregnancies had been postu-
lated to predispose to SCAD. However, these were not well described
in the literature.
METHODS Women with SCAD who have consented and are prospec-
tively followed in our Vancouver General Hospital SCAD registries are
included in this study. Their background hormonal exposure, preg-
nancy, and gynecological histories were extracted from question-
naires, clinical histories, and medical records. These were correlated
to in-hospital and long-term outcomes.
RESULTS We included 187 women with SCAD, with mean age 52.6 
8.7 years. The majority were Caucasian (83.4%) and 74.0% had
ﬁbromuscular dysplasia. All patients presented with MI. Mean num-
ber of pregnancy in this cohort was 2.5, with 45 (24.1%) and 25 (13.4%)
having 4 and 5 pregnancies, respectively. Mean number of live
births (parity) was 1.8, with 52 (27.8%) having 3 births, and 16 (8.6%)
having 4 births. There were 3 post-partum SCAD (<1 year) and they
were still breastfeeding. In terms of hormonal therapy, 28 (15.0%)
were actively on hormonal therapy; 5 (2.7%) had prior fertility treat-
ment, 51 (27.3%) had hormone replacement therapy (HRT), 76 (40.6%)
had oral contraception, and 36 (19.3%) had gynecological procedures.
There were 107 (57.2%) post-menopausal women, and 23 (12.3%) were
peri-menopausal at presentation. There was no death during acute
SCAD admission, but 3 died at follow-up (mean 4.1  3.9 years), and 36
(19.3%) had recurrent SCAD. Patients actively on hormones had higher
rate of recurrent SCAD (32.1% vs. 15.8%, p¼0.039). There was a higher
recurrent MI rate in premenopausal women during index admission
(8.9% vs. 1.9%, p¼0.037). There was no signiﬁcant difference in in-
hospital and follow-up events in women with past hormonal therapy,
post-partum women, or those with parity 4 or gravida 5.
CONCLUSIONS Signiﬁcant proportion of women with SCAD had
exposure to hormonal therapy or had multiple pregnancies/births.
Patients actively on hormonal therapy appeared to have higher
recurrent SCAD events at follow-up.
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BACKGROUND Percutaneous closure of ventricular septal rupture
(VSR) complicating acute myocardial infarction appears to be safe and
effective treatment, but there is no uniﬁed opinion about the inter-
vention timing for transcatheter closure due to the lack of large-scale
prospective clinical research.
METHODS Between October 2010 and April 2013, 43 consecutive ST-
elevation myocardial infarction (STEMI) complicating VSR patients
who had indications of primary transcatheter closure were enrolled in
our study. We excluded cardiogenic shock patients. These patients
were randomly assigned to either the early intervention group (n¼21)
or the late intervention group (n¼22). We applied percutaneous
closure of VSR within 2 weeks after STEMI for patients in early
intervention group, while we applied percutaneous closure of VSR in
6 weeks after STEMI for patients in late intervention group. We
recorded the procedure-related complications and followed up these
patients for 2 years.
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two groups. The procedure-related complications (major residual
shunting, left ventricular rupture, and device embolization) were
higher in early intervention group than in late intervention group [6/
21 (28%) vs. 4/22 (18%); p¼0.488], but the difference was not statis-
tically signiﬁcant. The patients in early intervention group had better
cardiac function at discharge (42%6% vs. 36%8% in left ventricular
eject fraction; p¼0.010). Occurrence of major adverse events (death,
myocardial infarction, and acute heart failure) was lower in early
intervention group than in late intervention group [5/21(24%) vs. 13/22
(59%); p for log-rank test ¼ 0.017].
CONCLUSIONS Early Interventional VSR closure is a promising tech-
nique, and could improve the prognosis of STEMI complicated with
VSR patients.
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BACKGROUND Percutaneous coronary intervention with stent im-
plantation is the standard of care in patients with ST-elevation
myocardial infarction (STEMI). However, coronary stents implanted in
patients with STEMI have higher risk of stent thrombosis (ST)
compared to non-STEMI patients; and ﬁrst-generation drug-eluting
stents have more risk of very-late ST than Bare-metal stents (BMS).
Pathophysiologic studies have been shown that the main cause of
very-late ST is lack of strut coverage (ratio of uncovered to total struts
per section (RUTSS) >30%). Second-generation of DES are aimed to
improve the coverage of the metallic struts; but long-term have not
been reported in patients with STEMI.
METHODS The EXAMINATION study is the ﬁrst randomized trial
comparing second-generation everolimus-eluting stents (EES) versus
BMS in patients with STEMI. A total of 169 consecutive event-free
patients included in the EXAMINATION study were screened to
participate in the RE-EXAMINATION study. Patients with fatal events,
target vessel revascularization, or with other important concomitant
diseases were excluded. All patients included in the RE-EXAMINA-
TION study underwent to coronary angiography and optical coher-
ence tomography (OCT) imaging 5 years after randomization. The
objective of the study was to compare the percentage of patients with
at least 1 OCT section with RUTSS >30% between EES and BMS. Other
OCT ﬁndings were also analyzed, such as: prevalence of malap-
position, neointima pattern and observation of neoatherosclerotic
lesions.
RESULTS A total of 65 patients were included (33 EES and 32 BMS). At
the time of index procedure both group had similar mean age (57.9 vs.
56.0 years; p¼0.479), gender (84.8% vs. 84.4% were males; p¼0.958),
diabetes mellitus (15.2% vs. 12.5%; p¼0.757), anterior myocardial
infarction (42.4% vs. 46.9%; p¼0.590) and Killip class I (84.8% vs.
90.6%; p¼ 0.572). Both groups were treated with similar number of
stents per patients (1.30 vs. 1.25; 0.639); maximal stent diameter (3.11
vs. 3.25 mm; p¼0.191) and total stent length (26.1 vs. 24.8 mm;
p¼0.629). A total of 49 patients have undergone to angiographic and
OCT imaging 5 years after stent implantation at June 2015. The study
will be completed in July 2015.
CONCLUSIONS The angiographic and OCT results of the study will be
presented in the TCT Congress.
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BACKGROUND The decision to perform cardiac catheterization
and percutaneous coronary intervention (PCI) in resuscitated patients
with sudden cardiac death remains controversial. Prior data suggest a
potential beneﬁt from percutaneous revascularization.
METHODS Using the Nationwide Inpatient Sample, we identiﬁed pa-
tients (n ¼ 275,325) with ventricular tachycardia or ﬁbrillation cardiac
arrest from 2000 to 2011. Primary outcome was in-hospital mortality.
We also measured the trends of PCI and in-hospital mortality during
study period.
RESULTS Out of 275,325 patients with VT or VF cardiac arrest, 52,695
patients underwent PCI. In-hospital mortality was 21.2% vs. 53.2% (P-
Value <0.0001) favoring PCI group. PCI use increased in VT or VF
cardiac arrest from 10.2% in 2000 to 24.2% in 2012 with 24% absolute
increase and 237% relative increase.
CONCLUSIONS PCI is underutilized in VT or VF cardiac arrest pa-
tients and those, who do not receive PCI, experienced increased
mortality. However, trends of PCI use are increased during the study
period.
CATEGORIES CORONARY: Angiography and QCA
KEYWORDS Cardiac arrest, Mortality, in-hospital, Percutaneous cor-
onary intervention
